Wisconsin Public Radio State health officials are warning Wisconsinites of a significant increase in cases of whooping cough. Data from ...

Omicron variant KP.3.1.1, also known as deFLuQE, made up over half (52.7%) of COVID-19 cases between Sept. 1 and Sept. 14. However, XEC and a variant known as MV.1 seem poised to become the next ...

Stay updated on the latest analyst actions and market trends with this financial article covering upgrades and downgrades for ...

The winter season ushers in a new globally spreading COVID-19 variant called XEC, a mix of KS.1.1 and KP.3.3, both from the ...

Journey through the scientific breakthroughs that have revolutionized our understanding of the universe, life, and everything in between.

XEC is also an offshoot of omicron, the widely spread variant that formed in 2021. According to experts, it has some of omicron’s features, too — like less severe symptoms and easy transmissibility.

FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...

Whooping cough cases have gone up in the U.S. compared to last year, according to new statistics from the Centers for Disease ...

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

The medtech segment achieved operational revenue growth of 4.4% despite ongoing weaknesses in the Chinese market. Notably, ...

The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between five and 49 years of age. Its approval has ...

Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...